Sengenics Awarded Prestigious Michael J. Fox Foundation Grant to Determine the Role of Autoantibodies in the Progression of Parkinson's

News Category Global Banking & Finance Reviews
Sengenics Awarded Prestigious Michael J. Fox Foundation Grant to Determine the Role of Autoantibodies in the Progression of Parkinson’s
Sengenics Awarded Prestigious Michael J. Fox Foundation Grant to Determine the Role of Autoantibodies in the Progression of Parkinson’s
Sengenics, the Functional Proteomics Company, has been awarded a prestigious research grant by The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to identify novel autoantibody signatures related to non-motor symptoms in individuals with high risk of Parkinsons disease (PD) from the Parkinsons Associated Risk Study (PARS). The objective of the study will be to leverage KREX-based Immunome protein arrays to identify autoantibodies that may have potential as diagnostic or mechanistic biomarkers and, furthermore, to help in understanding the aetiology of PD in terms of pathogenesis and disease progression. Sengenics will be the first external partner in the world to gain access to the PARS cohort.

Related Keywords

Nicole Polinski , Farah Elena , Jonathan Blackburn , Proteomics Company , Institute For Neurodegenerative Disorders , Michaelj Fox Foundation , Research Programs , Sengenics Corporation Pte Ltd , University Of Pennsylvania , Michaelj Fox Foundation For Parkinson Research , Functional Proteomics Company , Parkinsons Associated Risk Study , Neurodegenerative Disorders , Associate Director , Functional Proteomics , Corporation Pte , ஃபரா எலெனா , ஜொனாதன் கருப்பட்டி , ஆராய்ச்சி ப்ரோக்ர்யாம்ஸ் , பல்கலைக்கழகம் ஆஃப் பென்சில்வேனியா , பார்கின்சன்ஸ் தொடர்புடையது ஆபத்து படிப்பு , இணை இயக்குனர் , நிறுவனம் ட் ,